U.S. Markets close in 3 hrs 15 mins

Weakness Seen in AngioDynamics (ANGO): Stock Tumbles 7.8%

Zacks Equity Research

AngioDynamics Inc. (ANGO) saw a big move last session, as the company’s shares fell nearly 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ANGO, as the stock is now down nearly 17% in the past one-month time frame.

This slump shouldn’t be too much of a surprise to investors, as the medical instruments provider has seen 3 negative revisions in the past few weeks and its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

ANGO currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same sector include Delcath Systems, Inc. (DCTH), Syneron Medical Ltd. (ELOS) and Cyberonics Inc. (CYBX). While Delcath and Syneron sport a Zacks Rank #1 (Strong Buy), Cyberonics holds a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


ANGIODYNAMICS INC (ANGO): Free Stock Analysis Report

DELCATH SYSTEMS INC (DCTH): Free Stock Analysis Report

SYNERON MEDICAL LTD ORD (ELOS): Free Stock Analysis Report

CYBERONICS INC (CYBX): Free Stock Analysis Report

Zacks Investment Research